GCP
CLBT icon

GSA Capital Partners’s Cellebrite CLBT Stock Holding History

GSA Capital Partners’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-28,029
Closed -$448K – 1702
2025
Q2 		$448K Buy
+28,029
New +$500K 0.03% 1002
2025
Q1 		– Sell
-119,034
Closed -$2.62M – 1704
2024
Q4 		$2.62M Sell
119,034
-34,205
-22% -$658K 0.19% 44
2024
Q3 		$2.58M Sell
153,239
-78,496
-34% -$1.16M 0.19% 62
2024
Q2 		$2.77M Sell
231,735
-55,195
-19% -$617K 0.19% 58
2024
Q1 		$3.18M Buy
286,930
+244,357
+574% +$2.49M 0.25% 16
2023
Q4 		$369K Buy
+42,573
New +$331K 0.03% 998

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AE
Axon Enterprise Scottsdale, Arizona $19.1M AUM 8.75% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $4.21B AUM 44.81% 1-Year Est. Return

GSA Capital Partners's CLBT Position: Q3 2025 in Review

GSA Capital Partners sold out of Cellebrite (CLBT) in Q3 2025, closing a stake of 28,029 shares — an estimated $448K sold.

GSA Capital Partners first reported a position in CLBT in Q4 2023 and held it in 6 quarters. The position peaked at $3.18M in Q1 2024. 197 funds tracked by Wall St. Rank hold CLBT as of Q3 2025.

  • GSA Capital Partners reported no remaining Cellebrite position as of Q3 2025 after selling out during the quarter.
  • GSA Capital Partners sold 28,029 Cellebrite shares in Q3 2025, an estimated $448K.
  • GSA Capital Partners first reported a position in Cellebrite in Q4 2023 and held it in 6 quarters.
  • GSA Capital Partners's Cellebrite position peaked at $3.18M in Q1 2024.
  • 197 funds tracked by Wall St. Rank held Cellebrite as of Q3 2025.

Based on GSA Capital Partners's 13F filing for Q3 2025, filed 7 Nov 2025.